Cargando…
Establishment of Hepatitis C Virus RNA-Replicating Cell Lines Possessing Ribavirin-Resistant Phenotype
BACKGROUND: Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy using direct acting antivirals for patients with chronic hepatitis C. However, the precise mechanisms underlying RBV action against hepatitis C virus (HCV) replication are not yet understood....
Autores principales: | Satoh, Shinya, Mori, Kyoko, Ueda, Youki, Sejima, Hiroe, Dansako, Hiromichi, Ikeda, Masanori, Kato, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336140/ https://www.ncbi.nlm.nih.gov/pubmed/25699517 http://dx.doi.org/10.1371/journal.pone.0118313 |
Ejemplares similares
-
Genetic Characterization of Hepatitis C Virus in Long-Term RNA Replication Using Li23 Cell Culture Systems
por: Kato, Nobuyuki, et al.
Publicado: (2014) -
Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate‐activated protein kinase‐related kinases and retinoid X receptor α
por: Satoh, Shinya, et al.
Publicado: (2017) -
Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities
por: Gu, Weilin, et al.
Publicado: (2021) -
New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication
por: Ueda, Youki, et al.
Publicado: (2013) -
Correction: New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication
por: Ueda, Youki, et al.
Publicado: (2013)